Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04527315 · ClinicalTrials.gov registry record
COVID-19 Survivorship Registry
A clinical trial of Covid19, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT04527315 is a study of Covid19 that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 1,500 participants, below the 2,686-participant average among 94 other Covid19 trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04527315, a study of Covid19, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
COVID-19 is associated with acute pulmonary and cardiac injury. To better understand the degree and severity of cardiopulmonary injury as well as short and long-term sequelae of COVID-19 infection, this study will perform longitudinal study in patients who had recent known diagnosis of COVID-19.
Conditions Studied
Interventions
- OTHER Questionnaires
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2020-07-17 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04527315
The ClinicalTrials.gov registry entry for NCT04527315 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,686-participant average among 94 other Covid19 trials with a reported enrollment target (44% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT04527315 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04527315 about?
NCT04527315 is a clinical study titled "COVID-19 Survivorship Registry". COVID-19 is associated with acute pulmonary and cardiac injury. To better understand the degree and severity of cardiopulmonary injury as well as short and long-term sequelae of COVID-19 infection, this study will perform longitudinal study in patients who had recent known diagnosis of COVID-19.
What is the current status of trial NCT04527315?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2020-07-17. Estimated completion is 2027-12.
What conditions does trial NCT04527315 study?
This clinical trial studies the following conditions: Covid19.
What interventions are being tested in trial NCT04527315?
The interventions under investigation include: Questionnaires (OTHER).
Who is sponsoring clinical trial NCT04527315?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04527315 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
-
Defibrotide for the Treatment of Severe COVID-19
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.